MLAB — Mesa Laboratories Balance Sheet
0.000.00%
IndustrialsBalancedMid CapHigh Flyer
- $934.14m
- $1.10bn
- $184.34m
- 95
- 20
- 72
- 68
Annual balance sheet for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5.47 | 10.2 | 81.4 | 264 | 49.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.3 | 12.5 | 21.1 | 23.8 | 41.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 32 | 33.6 | 123 | 304 | 124 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23.6 | 22.2 | 24.5 | 23.8 | 38.8 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 164 | 157 | 409 | 601 | 707 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.3 | 23.7 | 26 | 32.6 | 48.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 64.7 | 45.5 | 189 | 195 | 314 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 99.4 | 111 | 220 | 406 | 394 |
Total Liabilities & Shareholders' Equity | 164 | 157 | 409 | 601 | 707 |
Total Common Shares Outstanding |